Date: 2015-02-17
Type of information: Opening of new premises
Compound: Chicago office
Company: Horizon Pharma (Ireland)
Therapeutic area:
Type agreement: opening of new premises
Action mechanism:
Disease:
Details:
- • On February 17, 2015, Horizon Pharma announced it has opened a Chicago office. The office, which is located at 150 South Wacker Drive , will primarily house commercial, corporate analytics and business development staff. The company's U.S. marketed products are Actimmune® (interferon gamma-1b), Duexis® (ibuprofen/famotidine), Pennsaid® (diclofenac sodium topical solution) 2% w/w, Rayos® (prednisone) delayed-release tablets and Vimovo® (naproxen/esomeprazole magnesium).
Financial terms:
Latest news:
Is general: Yes
